2016
DOI: 10.1007/s11094-016-1362-9
|View full text |Cite
|
Sign up to set email alerts
|

1-Substituted 2-Benzylaminobenzimidazoles with Phenyl Methoxyls: Synthesis, Computer Prediction, and Pharmacological Activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 6 publications
0
3
0
1
Order By: Relevance
“…Derivatives of 9-R-2-halogenophenyl-IMBI had a pronounced inhibitory effect on the processes of lipid peroxidation comparable to dibunol [15]. The compounds from the series of 1-substituted 2-benzylaminobenzimidazoles with phenyl methoxyls acted similarly [20]. Amides of 2,3-dihydroimidazo-and 2,3,4,10-tetrahydropyrimido[1,2-a]benzimidazolyl-acetic acids showed moderate AO activity compared to dibunol [18].…”
Section: The Resultsmentioning
confidence: 93%
See 1 more Smart Citation
“…Derivatives of 9-R-2-halogenophenyl-IMBI had a pronounced inhibitory effect on the processes of lipid peroxidation comparable to dibunol [15]. The compounds from the series of 1-substituted 2-benzylaminobenzimidazoles with phenyl methoxyls acted similarly [20]. Amides of 2,3-dihydroimidazo-and 2,3,4,10-tetrahydropyrimido[1,2-a]benzimidazolyl-acetic acids showed moderate AO activity compared to dibunol [18].…”
Section: The Resultsmentioning
confidence: 93%
“…Condensed benzimidazole derivatives were synthesized, and experimental screening of the antioxidant activity of new chemical compounds was carried out among the derivatives of 2-(hetaryl) imidazo[1,2-a]benzimidazoles (IMBI) [5], 3-aroyl-and 3-hetaroyl-IMBI [6], 2-methoxyphenyl-substituted 9-dialkylaminoethyl-IMBI [7], 2-methoxy-phenyl-and 2-oxyphenyl-substituted 1-dialkylaminoalkyl-IMBI [8], N-acylmethyl derivatives of 9H-2,3-dihydro-IMBI and 10H-2,3,4,10-tetrahydropyrimido[1,2-a]benzimidazoles [9], 9-dialkylaminoethyl-2-oxy(dioxy)phenyl-IMBI [10], aroylmethyl derivatives of tricyclic benzimidazole systems containing hydroxy groups in aroyl radicals [11] [17], amides of 2,3-dihydroimidazo-and 2,3,4,10-tetrahydropyrimido[1,2-a]benzimidazolyl-acetic acids [18], phenyl-and alkylthiocarbamides of 2,9-disubstituted IMBI [19], and 1-substituted 2-benzylaminobenzimidazoles with phenyl methoxyls [20]. Butylated hydroxytoluene (BHT, CAS Number 128-37-0), also known as dibunol, was chosen as a comparative drug.…”
Section: The Resultsmentioning
confidence: 99%
“…Антиоксидантные свойства конденсированных производных бензимидазола были изучены ранее [8,9] на модели аскорбат-зависимого ПОЛ. Было показано, что наибольшую антиоксидантную активность проявляли производные 9-диалкиламиноэтил-имидазобензимидазола (ИМБИ) с 3,4-диоксифенильным заменителем, которые в два раза превосходили препарат сравнения дибунол.…”
Section: Introductionunclassified
“…The presence of not one but two "privileged" fragments in the molecules of these compounds, namely, imidazoles, benzimidazoles and biphenyl should promote multitarget action. We also collected and analyzed the data on the activity of the synthesized biphenyl compounds with respect to a number of biological targets important for the therapy of diabetes mellitus and its vascular complications [33][34][35][36]. In view of these observations and in continuation of our research work on biologically active biphenyl derivatives, it is proposed to synthesize substituted biphenyl acid-amide derivatives by the condensation of 4-biphenyl acetic acid precursor first with thionyl chloride (to make its acid chloride) and then with different primary amines (aliphatic or aromatic).…”
mentioning
confidence: 99%